Related Experiment Video
Updated: Jun 8, 2025
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
Comparative Analysis of Plasma Protein Dynamics in Women with ST-Elevation Myocardial Infarction and Takotsubo
Shafaat Hussain1,2, Sandeep Jha1,2,3, Evelin Berger4
1Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, 413 45 Gothenburg, Sweden.
Insights
This study compared plasma proteins in women with ST-elevation myocardial infarction (STEMI) and Takotsubo syndrome (TS). Key protein differences were identified, offering potential diagnostic and therapeutic insights for these distinct cardiac conditions.
Area of Science:
- Cardiology
- Proteomics
- Biochemistry
Background:
- ST-elevation myocardial infarction (STEMI) and Takotsubo syndrome (TS) are distinct cardiac conditions with similar clinical presentations.
- Differentiating STEMI and TS is clinically challenging, necessitating molecular-level investigations.
Purpose of the Study:
- To compare plasma protein profiles in women with STEMI and TS during acute and stabilization phases.
- To identify molecular differences and shared pathophysiological mechanisms between STEMI and TS.
Main Methods:
- Quantitative proteomics was employed to analyze plasma proteins from STEMI and TS patients.
- Protein expression levels were assessed during acute (days 0-3) and stabilization (days 7, 14, 30) phases.
- Differential expression and functional significance of proteins were evaluated.
Main Results:
- STEMI patients exhibited higher levels of inflammation and tissue damage proteins, and reduced repair proteins compared to TS patients in the acute phase.
- STEMI patients showed ongoing inflammation and disrupted lipid metabolism in the stabilization phase.
- Consistent protein changes (e.g., SAA2, CRP, AGT) were observed in both conditions, suggesting shared mechanisms.
Conclusions:
- Plasma protein analysis revealed distinct molecular signatures for STEMI and TS in women.
- ADIPOQ, SAA2, CRP, SAA1, LBP, FGL1, AGT, MAN1A1, APOA4, COMP, and PCOLCE are identified as potential biomarkers.
- These identified proteins warrant further investigation for diagnostic and therapeutic applications in STEMI and TS.
Background:
ST-elevation myocardial infarction (STEMI) and Takotsubo syndrome (TS) are two distinct cardiac conditions that both result in sudden loss of cardiac dysfunction and that are difficult to distinguish clinically. This study compared plasma protein changes in 24 women with STEMI and 12 women with TS in the acute phase (days 0-3 post symptom onset) and the stabilization phase (days 7, 14, and 30) to examine the molecular differences between these conditions.
Methods:
Plasma proteins from STEMI and TS patients were extracted during the acute and stabilization phases and analyzed via quantitative proteomics. Differential expression and functional significance were assessed. Data are accessible on ProteomeXchange, ID PXD051367.
Results:
During the acute phase, STEMI patients showed higher levels of myocardial inflammation and tissue damage proteins compared to TS patients, along with reduced tissue repair and anti-inflammatory proteins. In the stabilization phase, STEMI patients exhibited ongoing inflammation and disrupted lipid metabolism. Notably, ADIPOQ was consistently downregulated in STEMI patients in both phases. When comparing the acute to the stabilization phase, STEMI patients showed increased inflammatory proteins and decreased structural proteins. Conversely, TS patients showed increased proteins involved in inflammation and the regulatory response to counter excessive inflammation. Consistent protein changes between the acute and stabilization phases in both conditions, such as SAA2, CRP, SAA1, LBP, FGL1, AGT, MAN1A1, APOA4, COMP, and PCOLCE, suggest shared underlying pathophysiological mechanisms.
Conclusions:
This study presents protein changes in women with STEMI or TS and identifies ADIPOQ, SAA2, CRP, SAA1, LBP, FGL1, AGT, MAN1A1, APOA4, COMP, and PCOLCE as candidates for further exploration in both therapeutic and diagnostic contexts.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:27Myocarditis II: Clinical features and Diagnostic Tests
01:21Myocarditis I: Introduction
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...